Bayesian adaptive group lasso with semiparametric hidden Markov models

Statistics in Medicine
Kai KangHongtu Zhu


This paper presents a Bayesian adaptive group least absolute shrinkage and selection operator method to conduct simultaneous model selection and estimation under semiparametric hidden Markov models. We specify the conditional regression model and the transition probability model in the hidden Markov model into additive nonparametric functions of covariates. A basis expansion is adopted to approximate the nonparametric functions. We introduce multivariate conditional Laplace priors to impose adaptive penalties on regression coefficients and different groups of basis expansions under the Bayesian framework. An efficient Markov chain Monte Carlo algorithm is then proposed to identify the nonexistent, constant, linear, and nonlinear forms of covariate effects in both conditional and transition models. The empirical performance of the proposed methodology is evaluated via simulation studies. We apply the proposed model to analyze a real data set that was collected from the Alzheimer's Disease Neuroimaging Initiative study. The analysis identifies important risk factors on cognitive decline and the transition from cognitive normal to Alzheimer's disease.


Aug 28, 2002·American Journal of Epidemiology·Joan LindsayIan McDowell
Nov 29, 2007·Dementia and Geriatric Cognitive Disorders·A BruandetF Pasquier
May 6, 2010·Journal of Alzheimer's Disease : JAD·Jose Viña, Ana Lloret
Jun 21, 2011·Journal of the Royal Statistical Society. Series B, Statistical Methodology·C YauC Holmes
Mar 2, 2012·Biometrics·Ruixin GuoJoseph G Ibrahim
Feb 5, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Kejal KantarciUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 17, 2013·Frontiers in Aging Neuroscience·Bradford C DickersonUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 1, 2013·Multivariate Behavioral Research·Sy-Miin ChowJohn J McArdle
Oct 1, 2005·Multivariate Behavioral Research·Verena D SchmittmannMichael C Neale
Mar 19, 2016·Lancet Neurology·Carolyn M Mazure, Joel Swendsen

❮ Previous
Next ❯


Apr 10, 2021·Statistical Methods in Medical Research·Xiaoxiao Zhou, Xinyuan Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.